Cefzlan 50 Dry Syrup is a pharmaceutical formulation containing cefixime, a broad-spectrum antibiotic effective against various bacterial infections. Designed for easy administration, this dry syrup is especially suitable for pediatric patients who may have difficulty swallowing tablets. Once reconstituted with water, it provides a palatable solution that ensures compliance in younger patients.
Cefixime works by inhibiting bacterial cell wall synthesis, thus preventing the growth and reproduction of bacteria. It is indicated for the treatment of infections such as otitis media, bronchitis, urinary tract infections, and certain types of gastrointestinal infections caused by susceptible strains of bacteria. Its efficacy in treating both gram-positive and gram-negative bacterial infections makes it a versatile choice in the clinical setting.
While generally well-tolerated, Cefzlan 50 may cause side effects in some individuals. Commonly reported side effects include gastrointestinal disturbances such as diarrhea, nausea, and abdominal pain. In rare cases, it may lead to allergic reactions, liver enzyme alterations, or superinfection due to resistant organisms. Patients should be monitored for any unusual symptoms and report them to their healthcare provider promptly.
To ensure the stability and efficacy of Cefzlan 50 Dry Syrup, it should be stored in a cool, dry place, away from direct sunlight and moisture. Once reconstituted, the syrup should be used within the recommended timeframe, usually within 7 to 14 days, and any unused solution should be discarded properly.